Page last updated: 2024-08-21

dronabinol and Cognition Disorders

dronabinol has been researched along with Cognition Disorders in 61 studies

Research

Studies (61)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (8.20)	18.7374
1990's	3 (4.92)	18.2507
2000's	25 (40.98)	29.6817
2010's	26 (42.62)	24.3611
2020's	2 (3.28)	2.80

Authors

Authors	Studies
Alessandria, G; Bandini, F; Capello, E; Infante, MT; Meli, R; Vestito, L	1
De Felice, M; Hudson, R; Laviolette, SR; Pereira, BJ; Renard, J; Rushlow, WJ; Schmid, S; Szkudlarek, HJ	1
Barhum, Y; Barzilay, R; Ben-Zur, T; Gazit, N; Gil-Ad, I; Hornfeld, SH; Kamiya, A; Niwa, M; Offen, D; Sawa, A; Segal-Gavish, H; Slutsky, I; Taler, M; Weizman, A	1
Barr, MS; George, TP; Goodman, MS; Herman, Y; Kiang, M; Kish, SJ; Rabin, RA; Remington, G; Zakzanis, KK	1
Calabrese, EJ; Rubio-Casillas, A	1
Sarne, Y	1
Jay, TM; Kebir, O; Krebs, MO	1
Beck, K; Borgan, F; Butler, E; Howes, OD; McCutcheon, R; Vernon, A; Veronese, M	1
Fishbein-Kaminietsky, M; Gafni, M; Sarne, Y	1
Burkhardt, H; Ehrenreich, H; Gerardy-Schahn, R; Hildebrandt, H; Jatho, J; Kröcher, T; Papiol, S; Röckle, I; Ronnenberg, A; Tantra, M; Winkler, D	1
Robinson, R	1
Canela, EI; Cordomí, A; de La Torre, R; Gasperini, P; Howell, LA; Lanfumey, L; Lluís, C; Maldonado, R; McCormick, PJ; Moreno, E; Navarro, G; Pardo, L; Pastor, A; Robledo, P; Viñals, X	1
Carr, F	1
Gabaglio, M; Parolaro, D; Prini, P; Rubino, T; Zamberletti, E	1
Ball, SA; D'Souza, DC; Radhakrishnan, R; Wilkinson, ST; Yarnell, S	1
Ciccone, CD	1
Bartesaghi, R; Braida, D; Capurro, V; Guidali, C; Guidi, S; Parolaro, D; Pinter, M; Realini, N; Rubino, T; Sala, M; Viganò, D	1
Alberio, T; Braida, D; Capurro, V; Fasano, M; Guidali, C; Parolaro, D; Realini, N; Rubino, T; Sala, M; Viganò, D	1
Curtis, A; Ives, N; Mitchell, I; Patel, S; Rickards, H	1
Cadet, JL; Darwin, WD; Herning, RI; Huestis, MA; Karschner, EL; Lowe, RH; Schwilke, EW	1
Bromley-Brits, K; Cai, F; Chen, B; He, G; Song, W; Zhang, X	1
Brüne, M; Della, B; Juckel, G; Norra, C; Roser, P; Uhl, I	1
Assaf, F; Fishbein, M; Gafni, M; Keren, O; Sarne, Y	1
Crane, NA; Crean, RD; Mason, BJ	1
Curran, HV; Demarchi, C; Freeman, TP; Gardener, C; Lewis, S; Morgan, CJ; Ramoutar, A; Rupasinghe, I; Schafer, G; Swan, S; Tan, N; Warrington, P; Wingham, G	1
Egashira, N; Fujiwara, M; Iwasaki, K; Manome, N; Mishima, K; Oishi, R	1
Dekker, N; Koeter, MW; Meijer, CJ; Meijer, JH; Quee, PJ; van Beveren, NJ	1
Braley, G; Carbuto, M; D'Souza, DC; Elander, J; Perry, E; Pittman, B; Radhakrishnan, R; Ranganathan, M; Sewell, RA	1
Taffe, MA	1
Brüne, M; Juckel, G; Lissek, S; Nicolas, V; Roser, P; Tegenthoff, M	1
Assaf, F; Fishbein, M; Gafni, M; Gov, S; Keren, O; Sarne, Y	1
Busquets-Garcia, A; Maldonado, R; Ozaita, A; Puighermanal, E	1
Egashira, N; Fujiwara, M; Iwasaki, K; Matsumoto, Y; Mishima, K	1
Manzanares, J; Palomo, T; Rubio, G; Urigüen, L	1
Kalant, H	1
Bechara, A; Lamers, CT; Ramaekers, JG; Rizzo, M	1
Kauert, G; Moeller, MR; Ramaekers, JG; Schneider, E; Theunissen, EL; van Ruitenbeek, P	1
Drukker, M; Fananás, L; Henquet, C; Krabbendam, L; Papiol, S; Ramaekers, JG; Rosa, A; van Os, J	1
Bhagwagar, Z; Makela, P; Robson, PJ; Rogers, RD; Wakeley, J	1
Hefetz, A; Keren, O; Pick, CG; Sarne, Y; Tselnicker, I	1
Linszen, D; van Amelsvoort, T	1
Khiabani, HZ; Mørland, J	1
Frampton, CM; Harvey, MA; Porter, RJ; Sellman, JD	1
Arnold, JC; Callaghan, PD; Dawson, B; Gunasekaran, N; Iwazaki, T; Kashem, MA; Long, LE; Mallet, PE; Matsuda-Matsumoto, H; Matsumoto, I; McGregor, IS; Quinn, HR; Thompson, MR	1
Campbell, VA; Downer, EJ; Gowran, A	1
Hefetz, A; Keren, O; Sarne, Y; Senn, R	1
Egashira, N; Fujiwara, M; Ishigami, N; Iwasaki, K; Mishima, K; Oishi, R	1
Almeida, PP; Bressan, RA; Lacerda, AL; Novaes, MA	1
Curran, HV; Mason, OJ; Morgan, CJ; Stefanovic, A	1
Schneider, M	1
Koethe, D; Leweke, FM	1
Baldwin, A; Pettingale, KW; Sensky, T	1
Ellinwood, EH; Johnson, K; Mathew, RJ; Wilson, WH	1
Copeland, K; Davis, CM; Fletcher, JM; Francis, DJ; Krauskopf, D; Morris, R; Naus, MJ; Page, JB; Satz, P	1
Battista, HJ; Fleischhacker, WW; Günther, V; Hummer, M; Kurzthaler, I; Miller, C; Sperner-Unterweger, B; Wechdorn, H	1
Croft, RJ; Gruzelier, JG; Mackay, AJ; Mills, AT	1
Gruber, AJ; Hudson, JI; Huestis, MA; Pope, HG; Yurgelun-Todd, D	1
Bickel, P; Dittrich, A; Schöpf, J; Zimmer, D	1
Deniker, P; Etevenon, P; Ginestet, D; Peron-magnan, P	1
Hooker, WD; Jones, RT	1
Chopra, GS	1

Reviews

14 review(s) available for dronabinol and Cognition Disorders

Article	Year
Biphasic effects of THC in memory and cognition. European journal of clinical investigation, 2018, Volume: 48, Issue:5 Topics: Age Factors; Alzheimer Disease; Animals; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Hippocampus; Humans; Marijuana Smoking; Memory Disorders; Memory, Short-Term; Neurogenesis; Nootropic Agents; Receptor, Cannabinoid, CB1	2018
Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders. European journal of pain (London, England), 2019, Volume: 23, Issue:7 Topics: Adolescent; Adult; Brain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Cannabis; Cognition Disorders; Cognitive Dysfunction; Dronabinol; Humans; Mental Disorders	2019
The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species. Psychopharmacology, 2019, Volume: 236, Issue:11 Topics: Animals; Cannabinoids; Cognition; Cognition Disorders; Dronabinol; Humans; Memory; Receptor, Cannabinoid, CB1; Species Specificity; Synaptic Transmission	2019
Marijuana Legalization: Impact on Physicians and Public Health. Annual review of medicine, 2016, Volume: 67 Topics: Automobile Driving; Cannabis; Cognition Disorders; Dronabinol; Humans; Illicit Drugs; Marijuana Abuse; Marijuana Smoking; Medical Marijuana; Opioid-Related Disorders; Prevalence; Psychotic Disorders; Public Health; United States	2016
Medical Marijuana: Just the Beginning of a Long, Strange Trip? Physical therapy, 2017, 02-01, Volume: 97, Issue:2 Topics: Cannabidiol; Cognition Disorders; Confusion; Controlled Substances; Depression; Dronabinol; Drug Administration Routes; Hallucinations; Heart; Humans; Lung; Marijuana Abuse; Medical Marijuana; Memory Disorders; Muscle Spasticity; Nausea; Pain; Physical Therapists; Postural Balance; Professional Role; Vomiting	2017
An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. Journal of addiction medicine, 2011, Volume: 5, Issue:1 Topics: Age of Onset; Cognition Disorders; Dose-Response Relationship, Drug; Dronabinol; Evidence-Based Medicine; Executive Function; Follow-Up Studies; Humans; Marijuana Abuse; Marijuana Smoking	2011
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids. Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2012, Dec-05, Volume: 367, Issue:1607 Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cognition; Cognition Disorders; Dronabinol; Endocannabinoids; Glycerides; Hippocampus; Humans; Memory; Neuronal Plasticity; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Synaptic Transmission; TOR Serine-Threonine Kinases	2012
Role of endocannabinoid system in mental diseases. Neurotoxicity research, 2004, Volume: 6, Issue:3 Topics: Analgesia; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Dronabinol; Endocannabinoids; Feeding Behavior; History, 20th Century; History, 21st Century; Humans; Mental Disorders; Movement Disorders; Receptor, Cannabinoid, CB1	2004
Adverse effects of cannabis on health: an update of the literature since 1996. Progress in neuro-psychopharmacology & biological psychiatry, 2004, Volume: 28, Issue:5 Topics: Accidents, Traffic; Automobile Driving; Cannabis; Cardiovascular Diseases; Cognition Disorders; Cohort Studies; Dronabinol; Humans; Longitudinal Studies; Marijuana Abuse; Marijuana Smoking; Neurotoxicity Syndromes; Psychomotor Performance; Public Health; Respiratory Tract Diseases; Risk; Schizophrenia	2004
Cannabis and psychosis: an update on course and biological plausible mechanisms. Current opinion in psychiatry, 2007, Volume: 20, Issue:2 Topics: Brain; Causality; Cerebrovascular Circulation; Cognition Disorders; Comorbidity; Dopamine; Dronabinol; Humans; Marijuana Abuse; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Psychoses, Substance-Induced; Risk Factors; Tomography, Emission-Computed, Single-Photon	2007
[Cannabis and cannabinoids as drugs]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2007, Mar-01, Volume: 127, Issue:5 Topics: Cannabinoid Receptor Antagonists; Cannabinoids; Cannabis; Cognition Disorders; Dronabinol; Humans; Piperidines; Psychoses, Substance-Induced; Psychotropic Drugs; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Risk Factors	2007
[Review: executive functioning and cannabis use]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999), 2008, Volume: 30, Issue:1 Topics: Attention; Cannabinoids; Cognition; Cognition Disorders; Concept Formation; Decision Making; Dronabinol; Frontal Lobe; Humans; Impulsive Behavior; Marijuana Abuse; Marijuana Smoking; Neuropsychological Tests	2008
Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure. Addiction biology, 2008, Volume: 13, Issue:2 Topics: Adolescent; Adult; Animals; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Child; Cognition Disorders; Dronabinol; Drug Tolerance; Humans; Marijuana Abuse; Neurons; Neuropsychological Tests; Psychoses, Substance-Induced; Puberty; Receptor, Cannabinoid, CB1; Risk Factors; Substance-Related Disorders	2008
Cannabis and psychiatric disorders: it is not only addiction. Addiction biology, 2008, Volume: 13, Issue:2 Topics: Affect; Animals; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Brain; Cannabinoid Receptor Modulators; Cannabinoids; Cognition Disorders; Depressive Disorder, Major; Dronabinol; Drug Interactions; Humans; Marijuana Abuse; Mood Disorders; Psychoses, Substance-Induced; Receptor, Cannabinoid, CB1; Risk Factors; Schizophrenia; Signal Transduction	2008

Trials

12 trial(s) available for dronabinol and Cognition Disorders

Article	Year
A pilot study using nabilone for symptomatic treatment in Huntington's disease. Movement disorders : official journal of the Movement Disorder Society, 2009, Nov-15, Volume: 24, Issue:15 Topics: Adult; Aged; Anti-Anxiety Agents; Behavioral Symptoms; Cognition Disorders; Cross-Over Studies; Disability Evaluation; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Huntington Disease; Male; Middle Aged; Neuropsychological Tests; Outcome Assessment, Health Care; Pilot Projects	2009
Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage. Behavioural brain research, 2011, Jun-20, Volume: 220, Issue:1 Topics: Analysis of Variance; Animals; Behavior, Animal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Interactions; GABA Antagonists; Male; Maze Learning; Mice; Mice, Inbred ICR; Neuropsychological Tests; Pentylenetetrazole; Psychotropic Drugs; Reaction Time; Recognition, Psychology; Time Factors	2011
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans. The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:9 Topics: Adolescent; Adult; Attention; Behavior; Cognition; Cognition Disorders; Double-Blind Method; Dronabinol; Drug Interactions; Euphoria; Female; Hallucinogens; Humans; Inhibition, Psychological; Injections, Intravenous; Male; Marijuana Abuse; Memory; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Orientation; Perception; Psychoses, Substance-Induced; Recognition, Psychology; Reward; Young Adult	2012
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls. Journal of psychopharmacology (Oxford, England), 2006, Volume: 20, Issue:2 Topics: Adult; Amphetamine-Related Disorders; Anxiety; Cognition Disorders; Decision Making; Depression; Discrimination Learning; Dronabinol; Drug Synergism; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Memory Disorders; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests; Problem Solving; Reaction Time; Serotonin Agents; Set, Psychology	2006
High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:10 Topics: Adult; Choice Behavior; Cognition Disorders; Cross-Sectional Studies; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Hallucinogens; Humans; Male; Marijuana Smoking; Multivariate Analysis; Neuropsychological Tests; Problem Solving; Psychomotor Disorders; Psychomotor Performance; Reaction Time; Time Factors	2006
An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2006, Volume: 31, Issue:12 Topics: Adolescent; Adult; Amino Acid Sequence; Amino Acid Substitution; Brain; Catechol O-Methyltransferase; Cognition Disorders; Cross-Over Studies; DNA Mutational Analysis; Dopamine; Double-Blind Method; Dronabinol; Environmental Exposure; Female; Genetic Predisposition to Disease; Genetic Testing; Genotype; Humans; Male; Middle Aged; Placebos; Polymorphism, Single Nucleotide; Psychoses, Substance-Induced; Psychotic Disorders	2006
The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:2 Topics: Adult; Age Factors; Attention; Brain; Catecholamines; Cognition; Cognition Disorders; Cross-Over Studies; Decision Making; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Neural Pathways; Neuropsychological Tests; Placebos; Psychotropic Drugs; Reaction Time; Receptor, Cannabinoid, CB1; Reinforcement, Psychology; Risk-Taking	2007
Effects of marijuana on performance of a computerized cognitive-neuromotor test battery. Psychiatry research, 1994, Volume: 51, Issue:2 Topics: Adult; Blood Pressure; Cannabis; Cognition Disorders; Diagnosis, Computer-Assisted; Double-Blind Method; Dronabinol; Heart Rate; Humans; Male; Memory Disorders; Motor Skills; Reaction Time; Self-Assessment; Substance-Related Disorders; Task Performance and Analysis	1994
Effect of cannabis use on cognitive functions and driving ability. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:6 Topics: Adult; Attention; Automobile Driving; Cognition; Cognition Disorders; Double-Blind Method; Dronabinol; Euphoria; Female; Headache; Humans; Libido; Male; Marijuana Abuse; Memory; Motor Skills; Nausea; Neuropsychological Tests; Physical Examination; Placebos; Psychiatric Status Rating Scales; Psychomotor Performance	1999
[Comparison of altered states of consciousness induced by the hallucinogens (--)-delta9-trans-tetrahydrocannabinol (delta9-THC) and N,N-dimethyltryptamine (DMT) (author's transl)]. Archiv fur Psychiatrie und Nervenkrankheiten, 1976, Dec-31, Volume: 223, Issue:1 Topics: Cognition Disorders; Consciousness; Dronabinol; Humans; N,N-Dimethyltryptamine; Surveys and Questionnaires; Tryptamines	1976
[Comparison of clinical effects of delta-9-tetrahydrocannabinol with the classic effects of hashish]. L'Encephale, 1975, Volume: 1, Issue:1 Topics: Adult; Affect; Attention; Cannabis; Clinical Trials as Topic; Cognition Disorders; Confusion; Dreams; Dronabinol; Electroencephalography; Euphoria; Female; Hallucinations; Humans; Intelligence; Male; Middle Aged; Perceptual Disorders; Personality Disorders; Substance-Related Disorders	1975
Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication. Psychopharmacology, 1987, Volume: 91, Issue:1 Topics: Adult; Arousal; Association; Attention; Cognition Disorders; Color Perception; Double-Blind Method; Dronabinol; Humans; Male; Memory Disorders; Reading; Verbal Behavior	1987

Other Studies

35 other study(ies) available for dronabinol and Cognition Disorders

Article	Year
Long-term assessment of the cognitive effects of nabiximols in patients with multiple sclerosis: A pilot study. Clinical neurology and neurosurgery, 2020, Volume: 196 Topics: Adult; Aged; Cannabidiol; Cognition; Cognition Disorders; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Muscle Spasticity; Neuropsychological Tests; Oral Sprays; Parasympatholytics; Pilot Projects; Prospective Studies; Single-Blind Method; Young Adult	2020
l-Theanine Prevents Long-Term Affective and Cognitive Side Effects of Adolescent Δ-9-Tetrahydrocannabinol Exposure and Blocks Associated Molecular and Neuronal Abnormalities in the Mesocorticolimbic Circuitry. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021, 01-27, Volume: 41, Issue:4 Topics: Animals; Anxiety; Cerebral Cortex; Cognition Disorders; Dronabinol; Glutamates; Glycogen Synthase Kinase 3; Hallucinogens; Male; Mood Disorders; Nerve Net; Neurons; Neuroprotective Agents; Oncogene Protein v-akt; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Social Behavior; Ventral Tegmental Area	2021
BDNF overexpression prevents cognitive deficit elicited by adolescent cannabis exposure and host susceptibility interaction. Human molecular genetics, 2017, 07-01, Volume: 26, Issue:13 Topics: Adolescent; Animals; Animals, Newborn; Brain-Derived Neurotrophic Factor; Cannabis; Cognition; Cognition Disorders; Disease Models, Animal; Dronabinol; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Psychotic Disorders	2017
Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:11 Topics: Adult; Cognition Disorders; Creatinine; Cross-Sectional Studies; Dronabinol; Female; Humans; Male; Marijuana Abuse; Neuropsychological Tests; Psychiatric Status Rating Scales; Retrospective Studies; Schizophrenia; Self Report; Statistics, Nonparametric; Substance Withdrawal Syndrome; Time Factors; Young Adult	2017
THC for age-related cognitive decline? Aging, 2018, 11-12, Volume: 10, Issue:12 Topics: Age Factors; Animals; Behavior, Animal; Brain; Cognition; Cognition Disorders; Cognitive Aging; Dronabinol; Humans; Mice; Neurogenesis; Neuroprotective Agents	2018
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage. Journal of neuroscience research, 2014, Volume: 92, Issue:12 Topics: Anilides; Animals; Arachidonic Acids; Brain; Camphanes; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cognition Disorders; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Encephalitis; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; PPAR gamma; Pyrazoles; Recognition, Psychology	2014
St8sia2 deficiency plus juvenile cannabis exposure in mice synergistically affect higher cognition in adulthood. Behavioural brain research, 2014, Dec-15, Volume: 275 Topics: Age Factors; Animals; Animals, Newborn; Brain; Cell Adhesion Molecules, Neuronal; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Gene Expression Regulation; Male; Maze Learning; Memory; Mice; Mice, Inbred C57BL; Mice, Transgenic; Psychotropic Drugs; Sialyltransferases	2014
Selective Reduction of THC's Unwanted Effects through Serotonin Receptor Inhibition. PLoS biology, 2015, Volume: 13, Issue:7 Topics: Animals; Brain; Cognition Disorders; Dronabinol; Humans; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A	2015
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. PLoS biology, 2015, Volume: 13, Issue:7 Topics: Amnesia; Analgesia; Animals; Anxiety; Brain; Cognition Disorders; Dimerization; Dorsal Raphe Nucleus; Dronabinol; HEK293 Cells; Humans; Hypothermia; Locomotion; Mice, Inbred C57BL; Mice, Transgenic; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A	2015
Neuropharmacology: Pain relief without pairing up. Nature reviews. Neuroscience, 2015, Volume: 16, Issue:9 Topics: Animals; Brain; Cognition Disorders; Dronabinol; Humans; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2A	2015
Cortical neuroinflammation contributes to long-term cognitive dysfunctions following adolescent delta-9-tetrahydrocannabinol treatment in female rats. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 2015, Volume: 25, Issue:12 Topics: Age Factors; Animals; Animals, Newborn; Cognition Disorders; Cyclooxygenase 2; Cytokines; Disease Models, Animal; Dronabinol; Encephalitis; Female; Gene Expression Regulation; Hallucinogens; Immobility Response, Tonic; Interpersonal Relations; Nitric Oxide Synthase Type II; Phosphodiesterase Inhibitors; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Swimming	2015
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood. Hippocampus, 2009, Volume: 19, Issue:8 Topics: Aging; Animals; Avoidance Learning; Cognition Disorders; Dendrites; Disks Large Homolog 4 Protein; Dronabinol; Glial Fibrillary Acidic Protein; Hippocampus; Intracellular Signaling Peptides and Proteins; Male; Maze Learning; Membrane Proteins; Memory; Neuronal Plasticity; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Synaptophysin; Tubulin; Vesicle-Associated Membrane Protein 2	2009
The depressive phenotype induced in adult female rats by adolescent exposure to THC is associated with cognitive impairment and altered neuroplasticity in the prefrontal cortex. Neurotoxicity research, 2009, Volume: 15, Issue:4 Topics: Analysis of Variance; Animals; Animals, Newborn; Area Under Curve; Avoidance Learning; Cognition Disorders; Depression; Disease Models, Animal; Disks Large Homolog 4 Protein; Dronabinol; Female; Glial Fibrillary Acidic Protein; Intracellular Signaling Peptides and Proteins; Maze Learning; Membrane Proteins; Neuronal Plasticity; Prefrontal Cortex; Proteomics; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Reaction Time; Synaptophysin; Tubulin	2009
Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. Journal of analytical toxicology, 2009, Volume: 33, Issue:8 Topics: Biomarkers; Cognition Disorders; Dronabinol; Gas Chromatography-Mass Spectrometry; Humans; Marijuana Smoking; Substance Abuse Detection; Substance-Related Disorders	2009
Effect of synthetic cannabinoid HU210 on memory deficits and neuropathology in Alzheimer's disease mouse model. Current Alzheimer research, 2010, Volume: 7, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain; Cannabinoid Receptor Modulators; Cognition Disorders; Conditioning, Psychological; Disease Models, Animal; Dronabinol; Female; Humans; Male; Maze Learning; Memory; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Treatment Failure	2010
Auditory mismatch negativity deficits in long-term heavy cannabis users. European archives of psychiatry and clinical neuroscience, 2010, Volume: 260, Issue:6 Topics: Acoustic Stimulation; Adult; Auditory Cortex; Auditory Perception; Cognition Disorders; Contingent Negative Variation; Dronabinol; Electroencephalography; Evoked Potentials, Auditory; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Memory Disorders; Receptors, Cannabinoid; Time	2010
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychological medicine, 2012, Volume: 42, Issue:2 Topics: Adolescent; Adult; Anxiety; Cannabidiol; Cognition Disorders; Depression; Dronabinol; Female; Hair; Humans; Illicit Drugs; Male; Marijuana Smoking; Memory; Psychoses, Substance-Induced; Schizotypal Personality Disorder; Young Adult	2012
Involvement of opioid system in cognitive deficits induced by ∆⁹-tetrahydrocannabinol in rats. Psychopharmacology, 2012, Volume: 219, Issue:4 Topics: Animals; Behavior, Animal; Cognition Disorders; Dronabinol; Male; Maze Learning; Memory Disorders; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu	2012
Cannabis and cognitive performance in psychosis: a cross-sectional study in patients with non-affective psychotic illness and their unaffected siblings. Psychological medicine, 2012, Volume: 42, Issue:4 Topics: Adolescent; Adult; Cognition; Cognition Disorders; Cross-Sectional Studies; Dronabinol; Female; Genetic Predisposition to Disease; Humans; Interview, Psychological; Male; Marijuana Abuse; Middle Aged; Neuropsychological Tests; Psychotic Disorders; Regression Analysis; Schizophrenia; Schizophrenic Psychology; Siblings; Young Adult	2012
Δ⁹Tetrahydrocannabinol impairs visuo-spatial associative learning and spatial working memory in rhesus macaques. Journal of psychopharmacology (Oxford, England), 2012, Volume: 26, Issue:10 Topics: Animals; Association Learning; Behavior, Animal; Cannabinoid Receptor Agonists; Cognition; Cognition Disorders; Dronabinol; Macaca mulatta; Male; Memory Disorders; Memory, Short-Term; Motor Skills; Motor Skills Disorders; Neurotoxicity Syndromes; Pattern Recognition, Visual; Psychotropic Drugs; Random Allocation; Receptor, Cannabinoid, CB1; Spatial Behavior; Visual Perception	2012
Alterations of theory of mind network activation in chronic cannabis users. Schizophrenia research, 2012, Volume: 139, Issue:1-3 Topics: Adult; Brain; Brain Mapping; Cognition Disorders; Dronabinol; Functional Laterality; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Marijuana Abuse; Neuropsychological Tests; Oxygen; Psychiatric Status Rating Scales; Theory of Mind; Young Adult	2012
Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling. Experimental brain research, 2012, Volume: 221, Issue:4 Topics: Animals; Cognition Disorders; Dronabinol; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Neuronal Plasticity; Neuroprotective Agents	2012
Involvement of reduced acetylcholine release in Delta9-tetrahydrocannabinol-induced impairment of spatial memory in the 8-arm radial maze. Life sciences, 2002, Dec-20, Volume: 72, Issue:4-5 Topics: Acetylcholine; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Cognition Disorders; Dronabinol; Hallucinogens; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Microdialysis; Physostigmine; Rats; Rats, Wistar; Space Perception; Tacrine	2002
A single low dose of tetrahydrocannabinol induces long-term cognitive deficits. Neuroscience letters, 2007, Jan-10, Volume: 411, Issue:2 Topics: Analysis of Variance; Animals; Behavior, Animal; Cognition Disorders; Dose-Response Relationship, Drug; Dronabinol; Maze Learning; Mice; Mice, Inbred ICR; Reaction Time; Time Factors	2007
The relationship between non-acute adolescent cannabis use and cognition. Drug and alcohol review, 2007, Volume: 26, Issue:3 Topics: Adolescent; Attention; Cognition Disorders; Comorbidity; Dronabinol; Female; Humans; Learning; Male; Marijuana Abuse; Memory, Short-Term; Neuropsychological Tests; New Zealand; Orientation; Substance Abuse Detection; Substance-Related Disorders; Wechsler Scales	2007
Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:5 Topics: Age Factors; Animals; Animals, Newborn; Avoidance Learning; Behavior, Animal; Cognition Disorders; Conditioning, Operant; Dronabinol; Drug Administration Schedule; Electrophoresis, Gel, Two-Dimensional; Hippocampus; Interpersonal Relations; Male; Maze Learning; Protein Processing, Post-Translational; Proteomics; Psychotropic Drugs; Rats; Rats, Wistar; Recognition, Psychology	2008
A comparison of the apoptotic effect of Delta(9)-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex. Brain research, 2007, Oct-17, Volume: 1175 Topics: Age Factors; Animals; Animals, Newborn; Apoptosis; Caspase 3; Cathepsin D; Cells, Cultured; Cerebral Cortex; Cognition Disorders; DNA Fragmentation; Dronabinol; Female; JNK Mitogen-Activated Protein Kinases; Male; Nerve Degeneration; Neurotoxins; Organ Culture Techniques; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1	2007
Long-term cognitive deficits induced by a single, extremely low dose of tetrahydrocannabinol (THC): behavioral, pharmacological and biochemical studies in mice. Pharmacology, biochemistry, and behavior, 2008, Volume: 88, Issue:3 Topics: Animals; Behavior, Animal; Blotting, Western; Brain Chemistry; Cognition Disorders; Dronabinol; Enzyme Induction; Extracellular Signal-Regulated MAP Kinases; Hallucinogens; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Piperidines; Psychomotor Performance; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant	2008
Delta9-Tetrahydrocannabinol-induced cognitive deficits are reversed by olanzapine but not haloperidol in rats. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Feb-15, Volume: 32, Issue:2 Topics: Acetylcholine; Animals; Antipsychotic Agents; Behavior, Animal; Benzodiazepines; Cognition Disorders; Dronabinol; Extracellular Space; Hallucinogens; Haloperidol; Hippocampus; Humans; Male; Marijuana Abuse; Maze Learning; Memory Disorders; Microdialysis; Olanzapine; Rats; Rats, Wistar	2008
The psychotomimetic states inventory (PSI): measuring psychotic-type experiences from ketamine and cannabis. Schizophrenia research, 2008, Volume: 103, Issue:1-3 Topics: Adolescent; Adult; Affective Symptoms; Anesthetics, Dissociative; Bipolar Disorder; Cognition Disorders; Delusions; Dronabinol; Female; Humans; Infusions, Intravenous; Ketamine; Marijuana Abuse; Paranoid Disorders; Perceptual Distortion; Personality Inventory; Psychoses, Substance-Induced; Substance Abuse Detection; Substance-Related Disorders	2008
Cannabinoids as antiemetics. British medical journal (Clinical research ed.), 1983, Mar-05, Volume: 286, Issue:6367 Topics: Adult; Antiemetics; Cannabinoids; Cognition Disorders; Dronabinol; Humans; Male	1983
Cognitive correlates of long-term cannabis use in Costa Rican men. Archives of general psychiatry, 1996, Volume: 53, Issue:11 Topics: Adult; Age Factors; Attention; Cognition Disorders; Cohort Studies; Costa Rica; Dronabinol; Female; Follow-Up Studies; Humans; Male; Marijuana Abuse; Memory Disorders; Memory, Short-Term; Middle Aged; Motor Skills; Pregnancy; Psychomotor Performance	1996
The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology, 2001, Volume: 153, Issue:3 Topics: Adolescent; Adult; Analysis of Variance; Cognition; Cognition Disorders; Dronabinol; Female; Hallucinogens; Humans; Male; Memory; N-Methyl-3,4-methylenedioxyamphetamine; Neuropsychological Tests	2001
Neuropsychological performance in long-term cannabis users. Archives of general psychiatry, 2001, Volume: 58, Issue:10 Topics: Adolescent; Adult; Cognition Disorders; Comorbidity; Dronabinol; Female; Humans; Male; Marijuana Abuse; Memory Disorders; Middle Aged; Neuropsychological Tests; Regression Analysis; Research Design; Severity of Illness Index; Substance Abuse Detection; Time Factors; Verbal Learning	2001
Studies on psycho-clinical aspects of long-term marihuana use in 124 cases. The International journal of the addictions, 1973, Volume: 8, Issue:6 Topics: Adult; Appetite; Attitude; Cannabis; Chemical and Drug Induced Liver Injury; Chronic Disease; Cognition Disorders; Dronabinol; Emotions; Humans; Inhibition, Psychological; Mental Disorders; Motivation; Movement Disorders; Nutrition Disorders; Phytotherapy; Respiratory System; Sexual Behavior; Social Behavior; Space Perception; Substance-Related Disorders; Tachycardia; Thinking; Time Factors; Time Perception	1973